New breast cancer drug candidate tested in healthy women first
Knowledge-focused
Recruiting now
This early-stage study tests a new drug called KSHN001034 in 40 healthy postmenopausal women to see if it is safe and how the body processes it. The drug is similar to an existing breast cancer treatment, Faslodex. Participants receive either the new drug or the existing one at d…
Phase: PHASE1 • Sponsor: Kashiv BioSciences, LLC • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:04 UTC